Life Science
Found 8 companies.
🏢 Dotmatics
👥 501-1000💰 $ Private on 2017-11-01PharmaceuticalComputerBiotechnologyBiopharmaBioinformaticsCloud ComputingLife ScienceSaaSData IntegrationData Visualization
Website LinkedIn Email Phone # Facebook Twitter

Dotmatics is an R&D scientific software company that specializes in connecting science, data, and decision-making. Their enterprise R&D platform and applications are designed to drive efficiency and accelerate innovation.

🏢 Apogee Therapeutics
👥 101-250💰 $149.0m Series B on 2022-12-07BiotechnologyTherapeuticsMedicalLife Science
Website LinkedIn

Apogee Therapeutics is a San Francisco-based biotechnology company, established in 2022, focused on developing innovative therapies for immunological and inflammatory disorders to meet patient needs.

🏢 Paradigm
👥 101-250💰 $203.0m Series A on 2023-01-25Life ScienceHospitalHealth CareHealth Diagnostics
Website LinkedIn Email

Paradigm is a company dedicated to transforming the clinical research ecosystem by developing a platform that provides equitable access to trials for all patients, improves trial efficiency, and lowers barriers to participation for healthcare providers.

🏢 Danaher
BiotechnologyMedicalLife ScienceHealth CareHealth Diagnostics
Website LinkedIn Email Phone # Facebook Twitter

Danaher Corporation is a global science and technology company that designs, manufactures, and markets a range of professional, medical, industrial, and commercial products and services across five segments: Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental, and Industrial Technologies.

🏢 Hamilton
👥 1001-5000BiotechnologyLife ScienceRoboticsManufacturing
Website LinkedIn Email Phone # Facebook Twitter

Hamilton is a leading biotechnology company specializing in precision measurement devices, automated liquid handling workstations, and sample management, with a commitment to quality and innovation for over 60 years.

🏢 Lonza
💰 $445.7m Post-IPO Debt on 2023-11-06PharmaceuticalBiotechnologyLife Science
Website LinkedIn Email Phone # Facebook Twitter

Lonza Group AG is a leading Life Sciences driven chemical company that provides active ingredients, chemical intermediates, and biotechnology solutions for the pharmaceutical and agrochemical sectors. With a focus on custom manufacturing and biopharmaceuticals, Lonza operates in three main divisions: Exclusive Synthesis & Biopharmaceuticals, Organic Fine & Performance Chemicals, and Polymer Intermediates, offering a wide range of products and services including microbial fermentation, therapeutic monoclonal antibodies, and various organic chemicals.

🏢 Seqera
👥 51-100💰 $21.9m Series A on 2022-10-25Big DataCloud ComputingLife ScienceSoftware
Website LinkedIn Email Twitter

Seqera makes complex data analysis accessible at any scale. Our software helps scientists solve today's most complex problems and drives innovation in genomics, global health, and beyond. Consolidating fragmented data and diverse computing resources into a unified platform, Seqera’s modern biotech stack is trusted by more than 150 leading life science organizations including AstraZeneca, Roche, and Johnson & Johnson. Scientists empowered with modern software engineering, conduct science faster, on larger datasets, and with more confidence. Seqera accelerates discoveries in an open world.

🏢 Ganymede
👥 1-10💰 $12.8m Series A on 2022-08-09BiopharmaLife SciencePaaSEnterprise SoftwareSoftware
Website LinkedIn Email Phone #

Ganymede is a low-code bio-aware PaaS for biotech software engineering, facilitating easy data integration and pipeline construction for software engineers in the biotech industry.